Whistleblower lawsuit accuses Orthofix of kickbacks scheme

Orthofix International

Orthofix (NSDQ:OFIX) allegedly participated in a scheme to defraud Medicare and state health programs with a kickbacks scheme designed to lure doctors into using the company’s neurological monitoring devices during orthopedic surgeries, according to a whistleblower lawsuit unsealed this week.

The lawsuit, revealed August 8 in the U.S. District Court for Middle Florida, alleges that Orthofix and its Blackstone subsidiary, a hospital and 2 doctors bilked the system by filing reimbursement claims for services that were never performed or were performed by unauthorized personnel.

Jason Schiff, the whistleblower, was asked to bid on a contract with the Parrish Medical Center in Florida to provide intraoperative neurophysiological monitoring services. In researching his bid, Schiff alleges, he discovered that a Blackstone sales rep named Mark Blair and Drs. Ara Jason Deukmedjian and Bharat Patel were using technology "so outdated it could not [emphasis theirs] make a real-time Internet connection," meaning no doctor was actually monitoring patients’ neurological activity during procedures.

"As a result, literally thousands of fraudulent IOM billings were submitted to Medicare / Medicaid and other government programs by the defendants, including and especially the ‘reading doctor,’ in most instances, Patel," according to the lawsuit. "There was no real-time reading of IOM data, Blair did not communicate telephonically with Patel from the operating room and Patel was not present at the hospital to read the IOM data in person."

Blair was also seen allegedly giving a cash-stuffed envelope to Deukmedjian and was later heard to brag that "it cost me over 20k to get Deuk’s business – but it was worth it,” according to the lawsuit. Parrish Medical Center and its administrators knew of the alleged arrangement between Blair and Deukmedjian, whose wife Sun Deukmedjian also allegedly participated in the scheme.

The lawsuit seeks a jury trial, a cease and desist order against the defendants’ allegedly illegal scheme, triple damages, civil penalties including $26,000 for each false claim and legal fees. Schiff is entitled to as much as 25% of any proceeds from the case.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply